Clinical trial Recruiting at 2 sites Interventional Ages 18 to 80

Del Nido vs Blood Cardioplegia for Heart Muscle Health During CABG

Official title: Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging

Run by Klinički Bolnički Centar Zagreb · NCT07637266 · Data updated 2026-11-12

This study tests whether Del Nido cardioplegia helps preserve heart muscle better than standard blood cardioplegia in people undergoing coronary artery bypass grafting.

More CABG trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorKlinički Bolnički Centar Zagreb
Academic / other
Locations2 sites (Zagreb and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedJune 1, 2027
Study endsJune 1, 2027
Registry record updatedJune 9, 2026
Trial IDNCT07637266 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with multi-vessel coronary artery disease scheduled for elective, isolated CABG requiring cardiopulmonary bypass and able to undergo MRI.

Probably not a fit

Patients with lower risk profiles or anatomy not favoring one cardioplegia approach may see no difference in outcomes.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with multi-vessel coronary artery disease undergoing isolated CABG are randomized to receive either Del Nido or blood cardioplegia during surgery. The primary assessment uses cardiac magnetic resonance imaging to measure myocardial viability, edema, fibrosis, and left ventricular function after surgery. CMR provides a noninvasive, highly sensitive view of how well the heart muscle is preserved with each protection strategy. The trial excludes cases needing other cardiac procedures, off-pump CABG, reduced ejection fraction under 30%, and MRI contraindications. LeadCenter is University Hospital Center Zagreb, with Klinički Bolnički Centar Zagreb as lead sponsor.

Why it matters

Potential benefit: If Del Nido cardioplegia proves superior, patients may experience better preservation of heart muscle and improved postoperative heart function.

How similar studies have gone: Prior data suggest Del Nido provides reliable protection, but few trials have used cardiac MRI to compare strategies directly in adults.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligibility Criteria:

1\. Patients with multivessel coronary artery disease scheduled for elective coronary artery bypass grafting

Exclusion Criteria:

1. Left ventricular ejection fraction \<30%
2. Associated cardiac procedures
3. Off-pump coronary artery bypass grafting
4. Contraindications for MRI
5. Inability to provide consent

Where it's running

  • University Hospital Center Zagreb
    Zagreb, Croatia
    Recruiting
  • University Hospital Center Zagreb
    Zagreb, Croatia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.